The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov.

Experts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases ...

The rising incidence of pancreatic cancer among young Americans may largely reflect previously undetected cases not a true rise in occurrence, experts say.

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

A recent analysis of pancreatic cancer data in young adults (aged 15–39) has found that although there is an increase in ...

With the support of the RiDYMO® platform, we are able to comprehensively explore various potential targets in drug ...

About Cardiff Oncology, Inc. Cardiff Oncology is a clinical ... ongoing and planned investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC) ...

An analysis of pancreatic cancer data in younger adults found that while there is an increasing incidence of pancreatic cancer in young adults, the mortality rate remains stable.

In the study, 34 patients with stage 4 metastatic pancreatic cancer were randomized ... the UI team also included cancer ...

A rise in the disease in younger people was not followed by an increase in deaths, a study found, and might be a sign of ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...